| HS code |
CIQ code |
HS System Commodity Name |
Gen Duty |
MFN Duty |
FTA Duty |
Excise Tax |
VAT |
Customs Clearance Code |
CIQ Inspection Code |
|
3004909078 |
 |
Single preparation, containing zilpaterol, put up in measured doses, packings for retail sale
已配剂量含齐帕特罗的单方制剂
|
30.0% |
0.0% |
0% ~ 0.0% |
0.0% |
13.0% |
L |
无 |
|
3004909079 |
|
Single preparations containing epitestosterone, put up in measured doses or packings for retail sale
已配剂量含表睾酮的单方制剂
|
30.0% |
0.0% |
0% ~ 0.0% |
0.0% |
13.0% |
L |
无 |
|
3004909081 |
|
Preparations containing Iron dextran, Tepoxalin and Butafosfan , veterinary, put up in measured doses or in forms of packings for retail sale
兽用已配剂量含右旋糖苷铁、替泊沙林、布他磷制剂
|
30.0% |
0.0% |
0% ~ 0.0% |
0.0% |
13.0% |
R |
无 |
|
3004909082 |
|
Preparations containing Nitroxinil , Flunixin meglumine and meloxicam , veterinary, put up in measured doses or in forms of packings for retail sale
兽用已配剂量含硝碘酚腈、氟尼辛葡甲胺、美洛昔康制剂
|
30.0% |
0.0% |
0% ~ 0.0% |
0.0% |
13.0% |
R |
无 |
|
3004909083 |
|
Single formulations containing 1-epiandrone (3 β - hydroxy-5 α - androsterol-1-ene-17-one) include retail packaging
含1-表雄酮(3β-羟基-5α-雄甾-1-烯-17-酮)的单方制剂
|
30.0% |
0.0% |
0% ~ 0.0% |
0.0% |
13.0% |
L |
无 |
|
3004909091 |
|
Medicaments containing FG-4592(CAS NO.:808118-40-3,a hypoxia inducible factor-proline hydroxylase inhibitor), put up in measured doses(including in forms or packings for retail sale)
含FG-4592（CAS号808118-40-3，一种缺氧诱导因子-脯氨酸羟化酶抑制剂）的已配定剂量的制剂
|
30.0% |
0.0% |
0% ~ 0.0% |
0.0% |
13.0% |
Q |
无 |
|
3004909092 |
|
Medicaments containing 5α-androstane-2-ene-17-ketone, put up in measured doses(including in forms or packings for retail sale)
已配剂量含5α-雄烷-2-烯-17-酮的单方制剂
|
30.0% |
0.0% |
0% ~ 0.0% |
0.0% |
13.0% |
L |
无 |
|
3004909093 |
|
Other medicaments, put up in measured doses(including in forms or packings for retail sale)
抗（防）癌药品制剂（不含癌症辅助治疗药品）
|
30.0% |
0.0% |
0% ~ 0.0% |
0.0% |
3.0% |
Q |
无 |
|
3004909094 |
|
Formula containing 2-androstenol (5a-androsterol-2-ene-17-ol) in prescribed dose ,including retail packaging
已配剂量含2-雄烯醇（5α-雄甾-2-烯-17-醇）的单方制剂
|
30.0% |
0.0% |
0% ~ 0.0% |
0.0% |
13.0% |
L |
无 |
|
3004909095 |
|
Formula containing 3-androstenol (5alpha-androsterol-3-ene-17-ol) in prescribed dose ,including retail packaging
已配剂量含3-雄烯醇（5α-雄甾-3-烯-17-醇）的单方制剂
|
30.0% |
0.0% |
0% ~ 0.0% |
0.0% |
13.0% |
L |
无 |
|
3004909096 |
|
Formula containing 3-androstenone (5a-androsterone-3-ene-17-one) in prescribed dose,including retail packaging
已配剂量含3-雄烯酮（5α-雄甾-3-烯-17-酮）的单方制剂
|
30.0% |
0.0% |
0% ~ 0.0% |
0.0% |
13.0% |
L |
无 |
|
3004909097 |
|
Bosentan Tablets, Antibiotics Tablets, Leoxiguan Tablets, Maxitengtan Tablets, Pifenidone Capsules, Nidanib Ethylsulfonate Soft Capsules, Imidase for Injection, Arabidase Alpha for Injection, Magastat Capsules, Salviate Hydrochloride Tablets, Penicillin T
波生坦片、安立生坦片、利奥西呱片、马昔藤坦片、吡非尼酮胶囊、乙磺酸尼达尼布软胶囊、注射用伊米苷酶、注射用阿糖苷酶α、麦格司他胶囊、盐酸沙丙蝶呤片、青霉胺片、利鲁唑片（已配定计量或制成零售包装）
|
30.0% |
0.0% |
0% ~ 0.0% |
0.0% |
3.0% |
Q |
无 |
|
3004909099 |
|
Other medicaments, put up in measured doses(including in forms or packings for retail sale)
其他已配定剂量的药品
|
30.0% |
0.0% |
0% ~ 0.0% |
0.0% |
13.0% |
Q |
无 |
